SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-19 |
| Reported value | $167,936,629 |
| Positions | 22 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| GENEDX HOLDINGS CORP | WGS | COM CL A | $115,058,099 | 884,654 |
| ARDELYX INC | ARDX | COM | $10,917,398 | 1,872,624 |
| BIOHAVEN LTD | BHVN | COM | $8,717,923 | 772,181 |
| TELADOC HEALTH INC | Unresolved | CALL | $4,550,000 | 650,000 |
| NOVAVAX INC | Unresolved | NOTE 5.000%12/1 | $4,032,000 | 600,000 |
| ARDELYX INC | Unresolved | CALL | $3,498,000 | 600,000 |
| QUIDELORTHO CORP | QDEL | COM | $3,378,391 | 118,291 |
| FORIAN INC | FORA | COM | $2,896,147 | 1,366,107 |
| PERSONALIS INC | PSNL | COM | $2,701,170 | 339,343 |
| BIOHAVEN LTD | Unresolved | CALL | $2,629,441 | 232,900 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.